Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Debt to Equity (2017 - 2025)

PAVmed has reported Debt to Equity over the past 5 years, most recently at $0.5 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 104.27% year-over-year to $0.5; the TTM value through Dec 2025 reached $0.5, up 104.27%, while the annual FY2025 figure was $0.5, 104.27% up from the prior year.
  • Debt to Equity for Q4 2025 was $0.5 at PAVmed, up from $0.21 in the prior quarter.
  • Over five years, Debt to Equity peaked at $4.1 in Q1 2023 and troughed at -$11.66 in Q4 2024.
  • A 4-year average of -$0.66 and a median of $0.21 in 2025 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: plummeted 653.47% in 2024 and later skyrocketed 110.23% in 2025.
  • Year by year, Debt to Equity stood at $3.08 in 2022, then tumbled by 159.8% to -$1.84 in 2023, then tumbled by 533.78% to -$11.66 in 2024, then surged by 104.27% to $0.5 in 2025.
  • Business Quant data shows Debt to Equity for PAVM at $0.5 in Q4 2025, $0.21 in Q3 2025, and $0.24 in Q2 2025.